HIV treatment Flashcards

1
Q

what are the primary goals of ART?

A
  • maximal and durable viral suppression
  • restoration and preservation of immune function (CD4 count)
  • improved quality of life
  • reduced HIV-related opportunistic infections (OIs)
  • reduced morbidity and mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the recommended treatment for most people with HIV?

A

INSTI (integrase strand transfer inhibitor) + 2 NRTIs (nucleoside/nucleotide reverse transcriptase inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some examples of treatments recommended for most people with HIV?

A
  • *BIC/FTC/TAF -> bictegravir/emtricitabine/tenofovir alafenamide
  • *DTG/ABC/3TC -> dolutegravir/abacavir/lamivudine
  • DTG + XTC + (TAF or TDF) -> dolutegravir + lamivudine + (tenofovir alafenamine or tenofovir disoproxil fumarate)
  • RAL + XTC + (TAF or TDF) -> raltegravir + lamivudine + (tenofovir alafenamine or tenofovir disoproxil fumarate)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is an example of a INSTI + 1 NRTI treatment?

A

DTG/3TC -> dolutegravir/lamivudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are some side effects of integrase inhibitors?

A
  • GI distress
  • CNS disturbances
  • Rash (less with BIC)
  • False elevation in creatinine
  • weight gain! (~10 pounds)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some DDIs with integrase inhibitors?

A
  • CATIONS (acid reducers), Metformin
  • others related to the other drugs used in the combination (like tenofovir and salicylates or nephrotoxic drugs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the integrase inhibitors for first-line ART?

A
  • Bictegravir (BIC)
  • Dolutegravir (DTG)
  • Raltegravir (RAL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are some advantages and disadvantages of Bictegravir (BIC)?

A

advantages
- STR (single tablet regimen) once daily with FTC/TAF
- few drug/food interaction
- high barrier to resistance

disadvantages
- least amount of data
- only available STR
- limited safety data in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are some advantages and disadvantages of Dolutegravir (DTG)?

A

advantages
- STR once daily with 3TC or 3TC/ABC
- also available as a single agent
- few drug/food interactions
- high barrier to resistance
- a preferred option for pregnant women in every trimester

disadvantages
- ABC coformulation requires HLA-B*5701 testing
- increases metformin levels
- limited safety data at conception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are some advantages and disadvantages of Raltegravir (RAL)?

A

advantages
- longest experience
- few drug/food interactions
- a preferred option for pregnant women

disadvantage
- multiple pills (no STR)
- lower barrier to resistance than BIC or DTG
- limited safety data at conception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are some INSTI STRs available for initial ART?

A
  • BIC/FTC/TAF (INSTI + dual NRTI)
  • DTG/3TC (INSTI + single NRTI)
  • DTG/3TC/ABC (INSTI + dual NRTI)
  • EVG/COBI/FTC/(TAF OR TDF) (Boosted INSTI + dual R+NRTI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical caveats of DTG/3TC

A

do NOT use if HIV-1 RNA > 500,000 c/mL, HBV coinfection, or without resistance testing results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which STR treatment requires HLA-B*5701 test to be NEGATIVE?

A

DTG/3TC/ABC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are some NNRTI STRs available for initial ART?

A
  • DOR/3TC/TDF
  • EFV/3TC/TDF
  • EFV/FTC/TDF
  • RPV/FTC/(TAF or TDF)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are some boosted PI STRs available for initial ART?

A

DRC/COBI/FTC/TAF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is important about RPV/FTC/(TAF or TDF)?

A

ONLY use if HIV-1 RNA < 100,000 c/mL AND CD4+ cell count > 200 cells/mm^2

17
Q

which integrase inhibitors should NOT be given with antacids?

A

DTG/RPV -> causes decrease in RPV
-> MOSTLY due to RPV

18
Q

what are the preferred regimen for ART in pregnancy and in non-pregnant women who are trying to conceive?

A

preferred regimens: ual NRTI backbone plus INSTI or boosted PI

alternative regimens: dual NRTI backbone plus NNRTI

19
Q

NRTI backbone for treatment in pregnant women/non-preg trying to conceive

A

preferred:
- 3TC/ABC
- FTC/TDF
- 3TC/TDF

alternative:
- FTC/TAF
- 3TC/ZDV

20
Q

what is significant about TAF?

A

spares kidneys

21
Q

preferred INSTI treatment in preg/non-preg trying to conceive?

A
  • DTG
  • RAL BID
    NO BIC due to caution in preg
22
Q

alternative NNRTI for preg/trying to conceive?

23
Q

preferred boosted PIs in preg/trying to conceive?

A
  • ATV/RTV
  • DRV/RTV BID
24
Q

when do we go to boosted PIs in therapy?

A

if know of resistance!

25
rapid ART initiation
- treat with RART immediately as soon as diagnosed - treat with RART regardless of CD4+ count, especially in older patients
26
why rapid ART/same day ART initiation?
- reduce loss to follow-up (i.e. patient forget to come back) and decrease tie to viral suppression
27
what are some adverse effects of NNRTIs? (class effect)
- liver toxicity - rash usually 6 weeks - hyperglycemia - hyperlipidemia
28
what is the clinical significance of Efavirenz (EFV)?
dosed at night due to side effects
29
what is the clinical significance of Rilpivirine (RPV)?
can cause neuropsychiatric effects
30
what is the clinical significance of Doravarine (DOR)?
only NNRTI that does not share NNRTI class effect adverse effects OR DDIs - despite not as many side effects, not as much efficacy
31
DDIs of NNRTIs
- Efavirenz, Nevirapine, and Etravirine are CYP3A4 INHIBITORS - Rilpivirine is a substrate of CYP3A4
32
TDF vs TAF
TDF - longer experience - preferred in pregnancy - available as generic NRTI combinations with 3TC and FTC TAF - less impact on markers of renal tubular dysfunction (NO RENAL TOXICITY)